Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

M/s. Genix Pharma (Pvt) Ltd.

Private pharmaceutical manufacturer · Karachi · Pakistan

Pharmaceutical manufacturer founded in 2004 with a broad portfolio of prescription and OTC medicines and an export presence.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗ LinkedIn ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date4 Aug 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Genix Pharma (Private) Limited
Company type
Private pharmaceutical manufacturer
Address
44, 45-B, Korangi Creek Road, Karachi-75190, Pakistan · 75190
Phone
+92 21 111 10 10 11
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000351 Genix Pharma (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000351 298 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx299public portfolio records represented
REG230unique registrations represented
IDX297indexed MedInfoBase presentations
SRC2additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR284current validated price records
G97generic molecules in indexed catalogue
DF12dosage-form groups
TA14therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage95%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage98%
priced packs safely normalized per unit
Comparable-market coverage87%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixM/s. Genix Pharma (Pvt) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/m-s-genix-pharma-pvt-ltdGenerated 23 Sep 2026Anti-infectives140 · 47%CNS & mental health43 · 14%Cardiovascular21 · 7%Gastrointestinal & hepatology19 · 6%Hematology & thrombosis15 · 5%Pain & musculoskeletal15 · 5%Endocrine & metabolic9 · 3%Other therapeutic areas35 · 12%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioM/s. Genix Pharma (Pvt) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/m-s-genix-pharma-pvt-ltdGenerated 23 Sep 2026297presentationsTablet156 · 53%Injection56 · 19%Suspension23 · 8%Capsule22 · 7%Infusion16 · 5%Solution12 · 4%Other forms12 · 4%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionM/s. Genix Pharma (Pvt) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/m-s-genix-pharma-pvt-ltdGenerated 23 Sep 2026258comparable productsBelow peer median47 · 18%Near peer median91 · 35%Above peer median120 · 47%Company median price position+4.8%Lowest-price equivalents32Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsM/s. Genix Pharma (Pvt) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/m-s-genix-pharma-pvt-ltdGenerated 23 Sep 2026Neutro Pharma (Pvt.) Ltd.,50 shared52% overlapNabiqasim Industries (Pvt) Ltd.,49 shared51% overlapMacter International Limited46 shared47% overlapGenome Pharmaceuticals (Pvt.) Ltd.46 shared47% overlapGlobal Pharmaceuticals (Pvt.) Ltd.45 shared46% overlapPharmasol (Pvt) Ltd.44 shared45% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives140 products · 47%
CNS & mental health43 products · 14%
Cardiovascular21 products · 7%
Gastrointestinal & hepatology19 products · 6%
Hematology & thrombosis15 products · 5%
Pain & musculoskeletal15 products · 5%
Endocrine & metabolic9 products · 3%
Respiratory & allergy9 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antivirals33 products · 11%
Antiepileptics24 products · 8%
Antimalarials20 products · 7%
Third-generation cephalosporins18 products · 6%
Fluoroquinolone antibacterials13 products · 4%
Macrolide antibacterials13 products · 4%
Antipsychotics12 products · 4%
Analgesics / NSAIDs11 products · 4%
Formulation footprint

Dosage forms

Tablet156 products
Injection56 products
Suspension23 products
Capsule22 products
Infusion16 products
Solution12 products
Drops4 products
Inhalation4 products
Cream1 products
Sachet1 products
Suppository1 products
Syrup1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 AclovirAciclovir 13presentations 200 mg, 200 mg/5 mL, 250 mg, 400 mg · Tablet, Syrup, Infusion #2 RecetamLevetiracetam 12presentations 100 mg/mL, 1000 mg, 250 mg, 500 mg · Solution, Tablet, Infusion #3 HadzoneCeftriaxone 11presentations 1 g, 2 g, 250 mg, 500 mg · Injection #4 ZyspanLinezolid 8presentations 100 mg/5 mL, 200 mg/100 mL, 400 mg, 400 mg/200 mL · Suspension, Solution, Tablet #5 EfecipCiprofloxacin 7presentations 125 mg/5 mL, 200 mg/100 mL, 250 mg, 250 mg/5 mL · Suspension, Infusion, Tablet #6 ExifinIbuprofen 7presentations 100 mg/5 mL, 200 mg/5 mL, 400 mg, 600 mg/100 mL · Suspension, Tablet, Infusion
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median4718% of comparable products
Near market median91within ±5% of median
Above market median12047% of comparable products
Lowest-price equivalents32ties included
Company median price position +4.8% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Vita-K 10 mg/mLPhytomenadione · Injection · 100's PKR 4.19/vial/unit-98.4% vs market median Amdivaz 250 mgMethyldopa · Tablet · 10X10's PKR 6.27/tablet-61.2% vs market median Monilstat 100,000 IU/mLNystatin · Oral drops · 30mL PKR 1.69/mL-43.4% vs market median Larith 500 mgClarithromycin · IV infusion · 1Vial PKR 170.61/vial/unit-41.2% vs market median Prozyl 500 mg/100 mLMetronidazole · IV infusion · 1Vial PKR 103.26/vial/unit-41.2% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 50shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 49shared generics Macter International Limited256 products · 93 generics 46shared generics Genome Pharmaceuticals (Pvt.) Ltd.181 products · 84 generics 46shared generics Global Pharmaceuticals (Pvt.) Ltd.224 products · 80 generics 45shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 44shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers228Distinct registrations among indexed, published, presentation-validated products only
Verified price observations297
Products with a verified price297
Products with multiple price observations0
Source records with multiple versions288
Latest portfolio source check22 Sep 2026
Latest effective price date4 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

230 unique registration(s) · 297 indexed presentation(s) · 2 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Aclovir Aciclovir 250 mg Powder for infusion 1 Vial 073690 PKR 805.45 PKR 805.45/vial/unit No comparator
Aclovir Aciclovir 500 mg Powder for infusion 1 Vial 073691 PKR 1,386.29 PKR 1,386.29/vial/unit No comparator
Aclovir Aciclovir 400 mg Tablet 40's 094871 PKR 2,363.63 PKR 59.09/tablet Near median
Aclovir Aciclovir 400 mg Tablet 10’s 094871 PKR 590.91 PKR 59.09/tablet Near median
Aclovir Aciclovir 400 mg Tablet 20's 094871 PKR 1,181.81 PKR 59.09/tablet Near median
Aclovir Aciclovir 400 mg Tablet 25s 094871 PKR 1,477.27 PKR 59.09/tablet Near median
Aclovir Aciclovir 400 mg Tablet 30's 094871 PKR 1,772.72 PKR 59.09/tablet Near median
Aclovir Aciclovir 400 mg Tablet 35’s 094871 PKR 2,219.98 PKR 63.43/tablet 7% above median
Aclovir Aciclovir 800 mg Tablet 2x 10’s 094872 PKR 1,427.13 PKR 71.36/tablet Near median
Aclovir Aciclovir 800 mg Tablet 10s 094872 PKR 664.77 PKR 66.48/tablet 10% below median
Aclovir Aciclovir 800 mg Tablet 25's 094872 PKR 1,661.93 PKR 66.48/tablet 10% below median
Aclovir Aciclovir 200 mg Tablet 1x 10’s 094873 PKR 388.28 PKR 38.83/tablet 8% above median
Aclovir Aciclovir 200 mg/5 mL Syrup 60ml 094874 PKR 310.63 PKR 5.18/mL No comparator
Afert Terbinafine 1 % Cream 10'g 123275 PKR 294.41 — No comparator
Albend Albendazole 200 mg Tablet 2's 083274 PKR 35.75 PKR 17.88/tablet 15% above median
Albend Albendazole 200 mg Tablet 10's 083274 PKR 164.01 PKR 16.40/tablet 5% above median
Amacin Amikacin 100 mg/2 mL Injection 2ml x 1's 083281 PKR 83.48 PKR 41.74/mL 15% above median
Amdivaz Methyldopa 250 mg Tablet 10X10's 115863 PKR 626.87 PKR 6.27/tablet 61% below median
Atrivir Entecavir 0.5 mg Tablet 30's 091182 PKR 9,565.58 PKR 318.85/tablet 10% below median
Atrivir Entecavir 0.5 mg Tablet 10's 091182 PKR 3,465.53 PKR 346.55/tablet Near median
Atrivir Entecavir 1 mg Tablet 30's 091183 PKR 15,941.34 PKR 531.38/tablet 10% below median
Atrivir Entecavir 1 mg Tablet 10's 091183 PKR 5,775.86 PKR 577.59/tablet Near median
Atrivir Entecavir 0.05 mg/mL Oral solution 120ml 101356 PKR 4,801.11 PKR 40.01/mL 7% below median
Bamiflu Oseltamivir 75 mg Capsule 10's 057718 PKR 2,252.59 PKR 225.26/capsule 87% above median
Caroxin Digoxin 0.05 mg Oral solution 120ml 091055 PKR 138.76 PKR 1.16/mL Near median
Caroxin Digoxin 0.05 mg Oral solution 60ml 091055 PKR 69.37 PKR 1.16/mL Near median
Colmixin Colistimethate sodium 1 MIU Powder for solution for IV injection 1's 107612 PKR 2,569.17 PKR 2,569.17/vial/unit 114% above median
Colmixin Colistimethate sodium 2 MIU Injection 1's 125292 PKR 2,000.07 PKR 2,000.07/vial/unit Near median
Cynacob Cyanocobalamin 1000 mcg Injection 1ml x 10's 088931 PKR 57.40 PKR 5.74/mL No comparator
D-TB Cycloserine 250 mg Capsule 30's 070867 PKR 4,522.62 PKR 150.75/capsule 6% above median
D-TB Cycloserine 250 mg Capsule 10's 070867 PKR 1,511.72 PKR 151.17/capsule 6% above median
D4U Cholecalciferol 5 mg Oral drops 10ml 075985 PKR 793.89 PKR 79.39/mL No comparator
Dabigat Dabigatran etexilate 75 mg Capsule 3x10's 125425 PKR 3,301.49 PKR 110.05/capsule 14% above median
Dabigat Dabigatran etexilate 150 mg Capsule 3x10's 125426 PKR 4,051.83 PKR 135.06/capsule 29% above median
Daclit Daclatasvir 30 mg Tablet 28's 084768 PKR 5,549.14 PKR 198.18/tablet Near median
Daclit Daclatasvir 60 mg Tablet 28's 084769 PKR 9,079.69 PKR 324.27/tablet Near median
Diphos Dihydroartemisinin + Piperaquine 40 mg + 320 mg Tablet 9's 061249 PKR 760.05 PKR 84.45/tablet Near median
Diphos Dihydroartemisinin + Piperaquine 40 mg + 320 mg Tablet 18's 061249 PKR 1,444.71 PKR 80.26/tablet 5% below median
Diphos Dihydroartemisinin + Piperaquine 40 mg + 320 mg Tablet 8's 061249 PKR 644.27 PKR 80.53/tablet Near median
Dopna Dopamine HCl 200 mg/5 mL Injection 1x5ml Amp 081455 PKR 142.52 — No comparator
Dopna Dopamine HCl 200 mg/5 mL Injection 10x5ml Amp 081455 PKR 1,425.30 — No comparator
DVpro Divalproex sodium 250 mg Tablet 30's 114458 PKR 189.08 PKR 6.30/tablet 15% below median
DVpro Divalproex sodium 250 mg Tablet 10's 114458 PKR 63.03 PKR 6.30/tablet 15% below median
DVpro Divalproex sodium 250 mg Tablet 20's 114458 PKR 126.06 PKR 6.30/tablet 15% below median
DVpro Divalproex sodium 500 mg Tablet 30's 114459 PKR 324.14 PKR 10.80/tablet 13% below median
DVpro Divalproex sodium 500 mg Tablet 10's 114459 PKR 108.05 PKR 10.81/tablet 13% below median
DVpro Divalproex sodium 500 mg Tablet 20's 114459 PKR 216.09 PKR 10.80/tablet 13% below median
Efecip Ciprofloxacin 250 mg Tablet 10's 015143 PKR 367.98 PKR 36.80/tablet 46% above median
Efecip Ciprofloxacin 500 mg Tablet 10's 018141 PKR 647.68 PKR 64.77/tablet 51% above median
Efecip Ciprofloxacin 750 mg Tablet 10's 047254 PKR 475.02 PKR 47.50/tablet 20% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). M/s. Genix Pharma (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/m-s-genix-pharma-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.